Mackenzie Price

Mackenzie Price practices at UMC Physicians in Lubbock, Texas.

Mackenzie Price's NPI, 1821391533, was assigned on December 20, 2010. Mackenzie Price holds Texas license PA06962.

Mackenzie Price's primary practice is UMC Physicians, at 5219 City Bank Pkwy, Lubbock, TX 79407 in Lubbock County. The practice phone is (806) 761-0333.

Mackenzie Price's primary practice is UMC Physicians in Lubbock, Texas. Mackenzie Price is also affiliated with University Medical Center. The medical group on file is UMC Physicians. Dmand AI also links Mackenzie Price to 1 more hospital, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mackenzie Price practices, 5 sites in all. Vendor and product names are available with a free account.

Physician assistant is Mackenzie Price's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Mackenzie Price is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Mackenzie Price is licensed in Texas.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, arthritis, chronic nasal allergies, chronic obstructive pulmonary disease (COPD), chronic sinusitis and contact dermatitis among the conditions Mackenzie Price treats.

CMS data shows 2,073 Medicare services from Mackenzie Price across 21 procedure codes in 2024, for 183 Medicare patients. Medicare paid $38,802 for them. Every service was in an office.

CMS counts 183 Medicare patients who saw Mackenzie Price in 2024. The largest group is 65 to 74, with 90 patients. 69% of them have high blood pressure, and 64% have high cholesterol. 7% are also on Medicaid. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mackenzie Price's median patient age at 68, with 59% women.

In 2024, Mackenzie Price wrote 5,507 Medicare Part D claims for 397 patients. 90% of them were for generic drugs. CMS names the drug for 4,904 of them, across 97 drugs with 11 or more claims each, at $290,005 in total drug cost.

Mackenzie Price accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Mackenzie Price from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $36.